MedPath

The Removing Port of the Laparoscopic Cholecystectomy Material

Not Applicable
Completed
Conditions
Wound Infection
Interventions
Procedure: Removing from Epigastric port
Registration Number
NCT02788942
Lead Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Brief Summary

Laparoscopic cholecystectomy is gold standard for gallstones. In this study the investigators are investigating the effect of the removing of cholecystectomy material from different ports, to the port site infections.

Detailed Description

Laparoscopic cholecystectomy is gold standard for gallstones. But there is no consensus about which port place is optimal for the removing of the cholecystectomy material from the abdomen. There are different port site infections rates in the literature. The minimal tissue damage of laparoscopic cholecystectomy suggests a lower risk of wound infection, but there are series with an infection range of 8 %. The investigators are investigating is there any difference at the port site infection rates when the cholecystectomy material removed from different ports from the abdomen at the laparoscopic cholecystectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Subject has cholelithiasis
Exclusion Criteria
  • Subject has perforated gallbladder
  • Subject has malignancy
  • Subject has increasing wall thickness of the gallbladder
  • Subject has malignancy in the preoperative ultrasonography in the gallbladder
  • Subject has pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EpigastricRemoving from Epigastric portThe cholecystectomy material will be removed from epigastric port. This will be experimental group. Port site infection rates will be measured.
Primary Outcome Measures
NameTimeMethod
Port site infections2 days

The cholecystectomy material will be removed from umbilical port at the control group, from the epigastric port at the experimental group. The port site infection rates will be noted.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sisli Etfal Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath